Quality assurance system
Based on lS09001/14001/45001 and China's "Drug Administration Law (DAL)"and "Biosafety Law (BL)", the company has formulated overall management policies and objectives, standardized the quality and safety of various activities carried out by the company, and gave maximum consideration to the impact on the environment, employee occupational health and other aspects, and has passed relevant certifications.
According to ICHQ10, China NMPA and other relevant international and domestic laws and regulations, carry out R&D and production management during the product life cycle and establish relevant management systems to ensure the legal compliance of R&D、non-clinical research, clinical research and production management activities.
